Tax changes could fuel biotech mergers, acquisitions

You are here: Home > Central Coast Health Watch > Current Article

Corporate tax cut could fuel biotech mergers, acquisitions

By Alex Kacik / Friday, January 6th, 2017 / Comments Off on Corporate tax cut could fuel biotech mergers, acquisitions

Proposals to streamline regulatory approval of new drugs would bode well for biotech companies like Amgen in Thousand Oaks. If President-elect Donald Trump reduces corporate income taxes as he proposed, it could bring an infusion of capital that could be a game changer for the tri-county biotech sector. Trump’s proposal to reduce corporate income taxes…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.